AwardedSpainGoods€36,676
Suministro de los principios activos denominados "Upadacitinib 45mg oral" Y "Risankizumab 360mg/2,4ml".
- Published
- Published 11 March 2025
Overview
El objeto del contrato viene determinado por el suministro de los principios activos denominados "UPADACITINIB 45MGORAL" Y "RISANKIZUMAB 360MG/2,4ML ".
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €36,676
- Procedure
- Direct
- Published
- 11 March 2025
Various medicinal products
Award outcome
- Awarded value
- €280,927
- Award date
- 29 January 2025
- ABBVIE SPAIN, S.L.U.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
11 March 2025
Contracting authority
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Procuring entityLas Palmas de Gran Canaria, Spain
ID_PLATAFORMA: 21050930148853
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.